1. Home
  2. RLJ vs PHVS Comparison

RLJ vs PHVS Comparison

Compare RLJ & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLJ
  • PHVS
  • Stock Information
  • Founded
  • RLJ 2011
  • PHVS 2015
  • Country
  • RLJ United States
  • PHVS Switzerland
  • Employees
  • RLJ N/A
  • PHVS N/A
  • Industry
  • RLJ Real Estate Investment Trusts
  • PHVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • RLJ Real Estate
  • PHVS Health Care
  • Exchange
  • RLJ Nasdaq
  • PHVS Nasdaq
  • Market Cap
  • RLJ 1.1B
  • PHVS 1.3B
  • IPO Year
  • RLJ 2011
  • PHVS 2021
  • Fundamental
  • Price
  • RLJ $7.64
  • PHVS $23.70
  • Analyst Decision
  • RLJ Hold
  • PHVS Buy
  • Analyst Count
  • RLJ 6
  • PHVS 6
  • Target Price
  • RLJ $9.35
  • PHVS $36.67
  • AVG Volume (30 Days)
  • RLJ 2.3M
  • PHVS 118.9K
  • Earning Date
  • RLJ 08-07-2025
  • PHVS 08-12-2025
  • Dividend Yield
  • RLJ 7.85%
  • PHVS N/A
  • EPS Growth
  • RLJ N/A
  • PHVS N/A
  • EPS
  • RLJ 0.20
  • PHVS N/A
  • Revenue
  • RLJ $1,367,020,000.00
  • PHVS N/A
  • Revenue This Year
  • RLJ $0.37
  • PHVS N/A
  • Revenue Next Year
  • RLJ $1.67
  • PHVS N/A
  • P/E Ratio
  • RLJ $38.36
  • PHVS N/A
  • Revenue Growth
  • RLJ 1.40
  • PHVS N/A
  • 52 Week Low
  • RLJ $6.16
  • PHVS $11.51
  • 52 Week High
  • RLJ $10.84
  • PHVS $26.33
  • Technical
  • Relative Strength Index (RSI)
  • RLJ 59.86
  • PHVS 64.13
  • Support Level
  • RLJ $7.54
  • PHVS $23.60
  • Resistance Level
  • RLJ $7.85
  • PHVS $24.52
  • Average True Range (ATR)
  • RLJ 0.19
  • PHVS 1.19
  • MACD
  • RLJ 0.07
  • PHVS 0.15
  • Stochastic Oscillator
  • RLJ 94.85
  • PHVS 82.13

About RLJ RLJ Lodging Trust of Beneficial Interest $0.01 par value

RLJ Lodging Trust is a real estate investment trust focused on premium-branded, rooms-oriented, high-margin, focused-service, and compact full-service hotels located within the heart of demand locations. Its hotels are geographically diverse and concentrated in urban markets providing multiple demand generators from business, leisure, and other travelers. Its hotels are under the Marriott, Hilton, and Hyatt brand names. The Hotel is a single reportable segment. Its hotel segment revenues are derived from the operation of hotel properties which includes room revenue by renting hotel rooms, food and beverage revenue from the sale of food and beverages, and other revenue from parking fees, resort fees, gift shop sales, and other guest service fees.

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

Share on Social Networks: